Shaping drug development with tumor organoids and RWD

Explore how Tempus addresses drug development challenges through its extensive 3D patient-derived organoid (PDO) biorepository and real-world data (RWD) platform.

Oct 04, 2024
Life Sciences
Webinar
Scott BoikoDirector of Translational Medicine, Nimbus Therapeutics
Richard Klinghoffer, PhDSVP, Head of Systems Biology, Tempus
Michelle Mack, PhDSenior Director of Business Development, Biological Modeling, Tempus

Related content

Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Smooth vertical gradient transitioning from dark blue to light blue and white.

2026 ASCO® Annual Meeting

2026-04-13
Providers
Life Sciences
Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Tempus-Events_Gradient-pill2x

ISPOR 2026

2026-04-09
Life Sciences
Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Tempus_5

ACRP 2026 Annual Conference

2026-04-01
Providers
Life Sciences